Meticulous Research®—a leading global market research company, published a research report titled, ‘Dialysis Market by Product (Haemodialysis [Dialyzers, Bloodlines, Dialysates {Alkaline, Acidic}, CVC, AV Fistula, AV Graft] Peritoneal Dialysis [Conventional, Nocturnal]), End User (Hospital, Homecare, Dialysis Center) – Global Forecast to 2031.’
According to this latest publication from Meticulous Research®, the dialysis market is projected to reach $36.6 billion by 2031, at a CAGR of 7.6% during the forecast period. The growth of this market is driven by the growing prevalence of kidney disorders, diabetes, and hypertension, the increasing number of dialysis centers, initiatives for chronic kidney care, shortage & side effects of kidney transplants, and the rising prevalence of early-stage renal disease. Additionally, technological advancements in dialysis machines, rising preference for home dialysis, and emerging economies are expected to offer significant market growth opportunities.
However, reimbursement issues in emerging economies and stringent regulatory policies for the approval and manufacturing of dialysis products restrain the growth of this market. Additionally, the rise in complications related to dialysis treatment, the high number of product recalls, and the high maintenance of hemodialysis equipment for small hospitals and ambulatory centers pose a significant challenge to the market's growth.
Key Players
The key players operating in the Dialysis market are Becton, Dickinson and Company (BD) (U.S.), Dialife SA (Switzerland), Fresenius Medical Care AG & Co. KGAA (Germany), Asahi Kasei Medical Co., Ltd. (Subsidiary of Asahi Kasei Corporation) (Japan), Wego Healthcare (Shenzhen) Co. Ltd. (China), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc (U.S.), Kawasumi Laboratories, Inc. (Japan), Nipro Corporation (Japan), Quanta Dialysis Technologies, Ltd. (U.S.), and Toray Industries, Inc. (Japan).
Dialysis Market: Future Out

Meticulous Research®—a leading global market research company, published a research report titled, ‘Dialysis Market by Product (Haemodialysis [Dialyzers, Bloodlines, Dialysates {Alkaline, Acidic}, CVC, AV Fistula, AV Graft] Peritoneal Dialysis [Conventional, Nocturnal]), End User (Hospital, Homecare, Dialysis Center) – Global Forecast to 2031.’
According to this latest publication from Meticulous Research®, the dialysis market is projected to reach $36.6 billion by 2031, at a CAGR of 7.6% during the forecast period. The growth of this market is driven by the growing prevalence of kidney disorders, diabetes, and hypertension, the increasing number of dialysis centers, initiatives for chronic kidney care, shortage & side effects of kidney transplants, and the rising prevalence of early-stage renal disease. Additionally, technological advancements in dialysis machines, rising preference for home dialysis, and emerging economies are expected to offer significant market growth opportunities.
However, reimbursement issues in emerging economies and stringent regulatory policies for the approval and manufacturing of dialysis products restrain the growth of this market. Additionally, the rise in complications related to dialysis treatment, the high number of product recalls, and the high maintenance of hemodialysis equipment for small hospitals and ambulatory centers pose a significant challenge to the market's growth.
Key Players
The key players operating in the Dialysis market are Becton, Dickinson and Company (BD) (U.S.), Dialife SA (Switzerland), Fresenius Medical Care AG & Co. KGAA (Germany), Asahi Kasei Medical Co., Ltd. (Subsidiary of Asahi Kasei Corporation) (Japan), Wego Healthcare (Shenzhen) Co. Ltd. (China), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc (U.S.), Kawasumi Laboratories, Inc. (Japan), Nipro Corporation (Japan), Quanta Dialysis Technologies, Ltd. (U.S.), and Toray Industries, Inc. (Japan).
Dialysis Market: Future Out